The role of microbiome in central nervous system disorders von Wang, Yan, Kasper, Lloyd H

Volltext

Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression von Ochoa-Repáraz, Javier, Mielcarz, Daniel W, Ditrio, Lauren E, Burroughs, Ashley R, Begum-Haque, Sakhina, Dasgupta, Suryasarathi, Kasper, Dennis L, Kasper, Lloyd H

Volltext

Digesting the emerging role for the gut microbiome in central nervous system demyelination von Joscelyn, Jennifer, Kasper, Lloyd H

Volltext

The Gut Microbiome and Multiple Sclerosis von Ochoa-Repáraz, Javier, Kirby, Trevor O, Kasper, Lloyd H

Volltext

Influence of the Gut Microbiome on Autoimmunity in the Central Nervous System von Colpitts, Sara L, Kasper, Lloyd H

Volltext

Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis von Ochoa-Reparaz, Javier, Mielcarz, Daniel W, Ditrio, Lauren E, Burroughs, Ashley R, Foureau, David M, Haque-Begum, Sakhina, Kasper, Lloyd H

Volltext

Gut microbiome and the risk factors in central nervous system autoimmunity von Ochoa-Repáraz, Javier, Kasper, Lloyd H.

Volltext

Multiple sclerosis immunology: The healthy immune system vs the MS immune system von KASPER, Lloyd H, SHOEMAKER, Jennifer

Volltext

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-contr... von Segal, Benjamin M, MD, Constantinescu, Cris S, MD, Raychaudhuri, Aparna, PhD, Kim, Lilianne, PhD, Fidelus-Gort, Rosanne, PhD, Kasper, Lloyd H, MD

Volltext

IL-9 as a mediator of Th17-driven inflammatory disease von Nowak, Elizabeth C, Weaver, Casey T, Turner, Henrietta, Begum-Haque, Sakhina, Becher, Burkhard, Schreiner, Bettina, Coyle, Anthony J, Kasper, Lloyd H, Noelle, Randolph J

Volltext

The evolving role of the gut microbiome in human disease von Kasper, Lloyd H.

Volltext

Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial von Bar‐Or, Amit, Calabresi, Peter A. J., Arnold, Douglas, Markowitz, Clyde, Shafer, Stuart, Kasper, Lloyd H., Waubant, Emmanuelle, Gazda, Suzanne, Fox, Robert J., Panzara, Michael, Sarkar, Neena, Agarwal, Sunil, Smith, Craig H.

Volltext

The Gut Microbiome in Multiple Sclerosis von Mielcarz, Daniel W., Kasper, Lloyd H.

Volltext

Gut, bugs, and brain: Role of commensal bacteria in the control of central nervous system disease von Ochoa-Repáraz, Javier, Mielcarz, Daniel W., Begum- Haque, Sakhina, Kasper, Lloyd H.

Volltext

The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders? von Ochoa-Repáraz, Javier, Kasper, Lloyd H.

Volltext

The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease von Ochoa-Repáraz, Javier, Kasper, Lloyd H

Volltext

A commensal bacterial product elicits and modulates migratory capacity of CD39+ CD4 T regulatory subsets in the suppression of neuroinflammation von Wang, Yan, Begum-Haque, Sakhina, Telesford, Kiel M, Ochoa-Repáraz, Javier, Christy, Marc, Kasper, Eli J, Kasper, Dennis L, Robson, Simon C, Kasper, Lloyd H

Volltext

The Microbiome and Neurologic Disease: Past and Future of a 2-Way Interaction von Ochoa-Repáraz, Javier, Kasper, Lloyd H.

Volltext

Alteration of CD39 + Foxp3 + CD4 T cell and cytokine levels in EAE/MS following anti-CD52 treatment von Pant, Anudeep B, Wang, Yan, Mielcarz, Daniel W, Kasper, Eli J, Telesford, Kiel M, Mishra, Megan, Haque, Azizul, Smith, Jacqueline, Kasper, Lloyd H, Begum-Haque, Sakhina

Volltext

Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis von Fadul, Camilo E., Mao-Draayer, Yang, Ryan, Kathleen A., Noelle, Randolph J., Wishart, Heather A., Channon, Jacqueline Y., Kasper, Isaac R., Oliver, Brant, Mielcarz, Daniel W., Kasper, Lloyd H.

Volltext